Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System

NCT04555161 is registered in ClinicalTrials.gov with Aria CV, Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04555161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
Lead sponsor
Aria CV, Inc
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2021
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary hypertension, right heart dysfunction